{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:13:43Z","timestamp":1793146423432,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.08.022","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:02:48Z","timestamp":1376560968000},"page":"5135-5142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural\/electrical remodeling"],"prefix":"10.1016","volume":"168","author":[{"given":"Fadia","family":"Mayyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem H.","family":"Alzoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Van Wagoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.08.022_bb0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCEP.109.880773","article-title":"Impact of dietary fatty acids on cardiac arrhythmogenesis","volume":"2","author":"Rennison","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0010","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/j.1540-8159.2000.tb07041.x","article-title":"Increased expression of P-selectin in patients with chronic atrial fibrillation","volume":"23","author":"Goette","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/hrt.2009.176321","article-title":"Lone atrial fibrillation: what do we know?","volume":"96","author":"Kozlowski","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0020","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0025-6196(11)60754-4","article-title":"Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies","volume":"84","author":"Crandall","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2013.08.022_bb0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.3949\/ccjm.70.Suppl_3.S2","article-title":"Basic mechanisms of atrial fibrillation","volume":"70","author":"Van Wagoner","year":"2003","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pcad.2005.06.013","article-title":"New antiarrhythmic drugs for prevention of atrial fibrillation","volume":"48","author":"Goldstein","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/138945011794182728","article-title":"Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling","volume":"12","author":"Raschi","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0045","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1006\/jmcc.2002.2088","article-title":"Molecular mechanisms of myocardial remodeling. The role of aldosterone","volume":"34","author":"Delcayre","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0060","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0065","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0070","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphys.2012.00105","article-title":"Nitric oxide synthases and atrial fibrillation","volume":"3","author":"Bonilla","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1262-3636(07)70122-2","article-title":"Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy","volume":"30","author":"Ambroisine","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/eurheartj\/ehi477","article-title":"Aldosterone antagonism and atrial fibrillation: time for clinical assessment?","volume":"26","author":"Nattel","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0095","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.20.1.67","article-title":"Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses","volume":"20","author":"Ullian","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0110","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","article-title":"Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways","volume":"31","author":"Newfell","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","article-title":"Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C","volume":"145","author":"Mihailidou","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0b013e328360c200","article-title":"Evolving research in nongenomic actions of aldosterone","volume":"20","author":"Williams","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0125","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin\u2013angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0008-6363(00)00307-2","article-title":"Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure","volume":"49","author":"Mihm","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yjmcc.2007.05.009","article-title":"Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology","volume":"43","author":"Babu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0145","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCRESAHA.108.171835","article-title":"Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects","volume":"103","author":"Briggs","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jacc.2005.09.051","article-title":"Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload","volume":"47","author":"Grieve","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0160","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.carpath.2008.12.014","article-title":"Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation","volume":"19","author":"Bukowska","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0165","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1074\/jbc.M306849200","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells","volume":"279","author":"Kaduce","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0170","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1111\/j.1742-4658.2005.04734.x","article-title":"Calcium-induced contraction of sarcomeres changes the regulation of mitochondrial respiration in permeabilized cardiac cells","volume":"272","author":"Anmann","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0175","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.18632\/aging.100261","article-title":"The NADPH oxidase Nox4 and aging in the heart","volume":"2","author":"Ago","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajh.2010.91","article-title":"Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb","volume":"23","author":"Kobayashi","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","article-title":"Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions","volume":"112","author":"Savoia","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10641960500468276","article-title":"Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in Dahl salt-sensitive rats","volume":"28","author":"Bayorh","year":"2006","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0205","first-page":"155","article-title":"Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure","volume":"51","author":"Bauersachs","year":"2003","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.regpep.2009.12.002","article-title":"Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice","volume":"160","author":"Kagiyama","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0215","doi-asserted-by":"crossref","first-page":"H1484","DOI":"10.1152\/ajpheart.01000.2010","article-title":"Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression","volume":"300","author":"Habibi","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0220","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0225","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/1470320310397405","article-title":"Study of the mechanisms of aldosterone prothrombotic effect in rats","volume":"12","author":"Gromotowicz","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/HYPERTENSIONAHA.107.109645","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats","volume":"52","author":"Michea","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1470320310391330","article-title":"Eplerenone suppresses aldosterone\/salt-induced expression of NOX-4","volume":"12","author":"Bayorh","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0240","doi-asserted-by":"crossref","first-page":"F1402","DOI":"10.1152\/ajprenal.00691.2010","article-title":"Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats","volume":"300","author":"Kawarazaki","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0245","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2003.11.173","article-title":"NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats","volume":"313","author":"Park","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0250","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yjmcc.2011.09.018","article-title":"Metabolic stress, reactive oxygen species, and arrhythmia","volume":"52","author":"Jeong","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0255","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2012.08.1021","article-title":"Mitochondria as a therapeutic target in heart failure","volume":"61","author":"Bayeva","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0260","first-page":"816","article-title":"Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases","volume":"87","author":"Pei","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0265","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/FJC.0b013e3181a15e77","article-title":"Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism","volume":"53","author":"Kamalov","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0270","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/07315724.1994.10718432","article-title":"Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review)","volume":"13","author":"Seelig","year":"1994","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0275","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389450033490948","article-title":"Aldosteronism in heart failure: a proinflammatory\/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets","volume":"4","author":"Weber","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0280","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cardfail.2006.11.015","article-title":"Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure","volume":"13","author":"Gao","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0285","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11906-012-0279-2","article-title":"Oxidative stress in the cardiorenal metabolic syndrome","volume":"14","author":"Whaley-Connell","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0290","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0002-8703(92)90613-Z","article-title":"Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes","volume":"124","author":"Morgera","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0295","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ehj.2004.04.035","article-title":"New hope for the prevention of recurrent atrial fibrillation","volume":"25","author":"Abdelhadi","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0300","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","article-title":"Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia","volume":"96","author":"Bruins","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0305","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2004.01.026","article-title":"Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation","volume":"148","author":"Conway","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2007.09.006","article-title":"Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study","volume":"155","author":"Marcus","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0315","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCGENETICS.110.959197","article-title":"Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project","volume":"4","author":"Schnabel","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0320","doi-asserted-by":"crossref","first-page":"R1742","DOI":"10.1152\/ajpregu.90995.2008","article-title":"The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6","volume":"297","author":"Sturgis","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0325","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0330","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/ndt\/gfn301","article-title":"Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension","volume":"23","author":"Klanke","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0335","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0340","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0345","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/en.2006-1157","article-title":"Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system","volume":"148","author":"Hirono","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","article-title":"Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats","volume":"317","author":"Zhao","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0355","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1476-5381.2010.00675.x","article-title":"Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation","volume":"159","author":"Lendeckel","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0360","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","article-title":"Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts","volume":"47","author":"Kobayashi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cardfail.2005.08.005","article-title":"The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure","volume":"12","author":"Kotlyar","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0370","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0375","doi-asserted-by":"crossref","first-page":"H1279","DOI":"10.1152\/ajpheart.00148.2008","article-title":"Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho\/Rho-kinase, and PPARs in cardiomyocytes","volume":"295","author":"Doi","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0380","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","article-title":"Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death","volume":"165","author":"Xiao","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0385","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0390","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0395","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/jmcc.1997.0612","article-title":"Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade","volume":"30","author":"Ramires","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0400","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0405","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)99016-0","article-title":"Gene expression in distinct regions of the heart","volume":"355","author":"Thum","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/gerona\/62.4.382","article-title":"Aldosterone antagonism fails to attenuate age-associated left ventricular fibrosis","volume":"62","author":"Hwang","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0415","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yjmcc.2005.04.001","article-title":"Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo","volume":"39","author":"Burniston","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0420","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.102673599","article-title":"Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes","volume":"99","author":"Beggah","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00029330-200801010-00008","article-title":"Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs","volume":"121","author":"Yang","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0430","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.107.748053","article-title":"Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences","volume":"117","author":"Burstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0435","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/nar\/gkm923","article-title":"Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation","volume":"36","author":"Sanchez-Guerrero","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0440","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0445","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0450","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e318033dfd4","article-title":"Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation","volume":"49","author":"Nishioka","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0455","first-page":"567","article-title":"Aldosterone stimulating PDGF-B expression in HSC via activation of EGR-1","volume":"13","author":"Li","year":"2005","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0460","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/gast.2003.50058","article-title":"Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells","volume":"124","author":"Caligiuri","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0465","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.transproceed.2007.11.025","article-title":"Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity","volume":"40","author":"Macunluoglu","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0470","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/CIRCEP.109.924985","article-title":"Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease","volume":"3","author":"Mayyas","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0475","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2009.08.064","article-title":"Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation","volume":"55","author":"Adam","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0480","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","article-title":"Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1","volume":"16","author":"Terada","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0490","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/B:CEPR.0000023146.37030.8c","article-title":"Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update","volume":"7","author":"Asher","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0495","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.RES.85.11.1056","article-title":"Virtual electrode-induced reexcitation: a mechanism of defibrillation","volume":"85","author":"Cheng","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0500","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.81.4.512","article-title":"Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation","volume":"81","author":"Yue","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0505","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.RES.85.12.1139","article-title":"Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes","volume":"85","author":"Benitah","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0510","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2005.05.009","article-title":"Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes","volume":"67","author":"Lalevee","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0515","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00210-010-0553-2","article-title":"Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits","volume":"382","author":"Laszlo","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3317\/jraas.2008.014","article-title":"Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia","volume":"9","author":"De Mello","year":"2008","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0525","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0008-6363(99)00178-9","article-title":"Ionic mechanisms of electrical remodeling in human atrial fibrillation","volume":"44","author":"Bosch","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0530","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1469-7793.2001.0151k.x","article-title":"Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes","volume":"537","author":"Benitah","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0535","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1159\/000178483","article-title":"Spironolactone prevents aldosterone induced increased duration of atrial fibrillation in rat","volume":"29","author":"Lammers","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0540","first-page":"1452","article-title":"The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes","volume":"77","author":"Christ","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0545","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.yjmcc.2008.08.015","article-title":"Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin","volume":"45","author":"Liu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0550","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/bbrc.1995.2106","article-title":"Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha","volume":"213","author":"Christ","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0555","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.108.184044","article-title":"Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart","volume":"104","author":"Qu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0560","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2011","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.ijcard.2013.08.022_bb0565","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehn383","article-title":"Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction","volume":"29","author":"Palmer","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0570","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurheartj\/ehr292","article-title":"Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction","volume":"33","author":"Edelmann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0575","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/clc.20689","article-title":"Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation","volume":"33","author":"De-An","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0580","first-page":"626","article-title":"Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation","volume":"37","author":"Luo","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0585","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.amjcard.2008.03.063","article-title":"Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure","volume":"102","author":"Amir","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0590","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000095671","article-title":"Raised plasma aldosterone and natriuretic peptides in atrial fibrillation","volume":"108","author":"Dixen","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0595","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0002-9149(01)01905-1","article-title":"Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation","volume":"88","author":"Goette","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0600","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1540-8159.2009.02673.x","article-title":"A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation","volume":"33","author":"Wozakowska-Kaplon","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0605","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0610","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1476-5381.2009.00551.x","article-title":"Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing","volume":"159","author":"Zhao","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0615","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1540-8167.2006.00372.x","article-title":"Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure","volume":"17","author":"Shroff","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0620","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1152\/ajpheart.00637.2010","article-title":"Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization","volume":"301","author":"Bafford","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0625","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2012.12.020","article-title":"Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation","volume":"111","author":"Ito","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0630","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0635","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0008-6363(03)00251-7","article-title":"Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure","volume":"58","author":"Cittadini","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0640","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jjcc.2010.11.006","article-title":"Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure","volume":"57","author":"Kimura","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0645","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehn277","article-title":"Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone","volume":"29","author":"Mulder","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0650","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FJC.0b013e3182495543","article-title":"SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats","volume":"59","author":"Nariai","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0655","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0660","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.amjcard.2010.07.037","article-title":"Effect of combined spironolactone-beta-blocker\u00b1enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study)","volume":"106","author":"Dabrowski","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0665","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11739-009-0229-4","article-title":"A beneficial effect of 3-year spironolactone therapy supplementing atenolol therapy on the remodeling of atria and ventricles in a patient with permanent atrial fibrillation","volume":"4","author":"Dabrowski","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0670","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0675","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2006.09.006","article-title":"Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation","volume":"153","author":"Richter","year":"2007","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ijcard.2013.08.022_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2012.02.009","article-title":"Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials","volume":"165","author":"Khatib","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.022_bb0685","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ijcard.2013.08.022_bb0690","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/jhh.2012.21","article-title":"Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design","volume":"27","author":"Rossi","year":"2012","journal-title":"J Hum Hypertens"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313015477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313015477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T21:10:12Z","timestamp":1563657012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313015477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313015477"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.022","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural\/electrical remodeling","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}